For anyone wanting more information about MANF I thought this was a great post to reference.

AMBS is the most undervalued stock in the market.

I wouldn't bet on it.

The Chinese will continue to accumulate tremendous amounts of gold as part of their plan to have a "gold backed" Yuan replace the dollar as the "world standard" currency. The Yuan recently passed the Euro and moved into second place as the currency most used globally in trade transactions.

http://finance.yahoo.com/news/china-probe-foreign-currency-trade-144918869.html

Yuan Passes Euro as 2nd-Most Used Trade-Finance Currency

http://www.bloomberg.com/news/2013-12-03/yuan-passes-euro-to-be-second-most-used-trade-finance-currency.html

p.s. Gold is at or near the bottom here.

The Chinese will continue to accumulate tremendous amounts of gold as part of their plan to have a "gold backed" Yuan replace the dollar as the "world standard" currency. The Yuan recently passed the Euro and moved into second place as the currency most used globally in trade transactions.

http://finance.yahoo.com/news/china-probe-foreign-currency-trade-144918869.html

Yuan Passes Euro as 2nd-Most Used Trade-Finance Currency

http://www.bloomberg.com/news/2013-12-03/yuan-passes-euro-to-be-second-most-used-trade-finance-currency.html

p.s. Gold is at or near the bottom here.

AMBS is under strong accumulation. The total short volume for the week was in the 45% range.

New and existing shareholders are pulling shares out of the float for a long term hold. The up trend in the share price will continue and I expect one p.r. will double the share price in a day and AMBS will be on its way to up listing to the NASDAQ before the end of the second quarter of 2014.

The J.P. Morgan Healthcare Conference and the T.B.I. presentation at the United Nations are just two of the catalysts that will result in additional exposure of the company to the media and to new shareholders. The penny flippers and the shorts will be chasing the share price going forward.

Follow the company on Twitter: @AmarantusBio

Sound analysis.

Gold at $1,400 and NUGT at $40.00 by the end of December.

Shorts are trying to keep a lid on the share price at .06.

Shorting million of shares here.

Interesting days ahead.

Done to $23.00?

http://regsho.finra.org/FNSQshvol20131204.txt

Just change the date in the address. The daily report is typically published at 6:30 p.m. e.s.t.

I don't think gold will go below $1,135 and I don't think "NUGT" will go below $23.50.

Of course I wouldn't bet on either.

I still expect the trade volume on the day is goes over .10 will be in the 50,000,000 share range.

Just saying!!!

It appears very evident that AMBS is under accumulation currently. The shorts are making every effort to keep a lid on the share price.

It will be interesting to see what percentage of today's volume was "short" sales. The FINRA report will be out at 6:30 E.S.T. I'm expecting it to be above 40%.

.10 by next week.

Up listing to NASDAQ second quarter 2014.

I'm expecting the up listing to the NASDAQ in the second quarter of 2014 with the share price being in the .50 range by the end of 2014.

"Patience is a virtue."

p.s. Yes that's 800-1,000% upside from today.

I think the relatively few shares that convert at .10 are irrelevant to where the share price will be in a year when AMBS is trading on the NASDAQ.

I never thought "NUGT" could go below $20.00 but now I wouldn't bet against it.

Good luck to all.

The only way that the shorts can keep a lid on AMBS's share price is to short more shares as the share price climbs. They keep digging their grave deeper with every higher priced share sold "short".

That is what happened when VRML went from one cent to over $35.00.

If you've never seen a short squeeze in real time it's very interesting to watch as the "ASK" gets continually taken out and nothing gets bought at the "BID".

A "Merry Christmas" and a "Happy New Year" for the AMBS longs.

Not so much for the shorts.

p.s. "Patience is a virtue."


Twitter: @AmarantusBio

Below $25.00 today seems likely.

Wish I knew where the bottom will be.

This is setting up for a "short squeeze" run back to the 52 week high in the .20 range. I think it will hold that range and move higher from there as the time frame for the up listing to NASDAQ shrinks. My expectation is that the up listing will occur in the second quarter of 2014.

The shorts are struggling to keep a lid on the share price as follows:

12/2: 2,582,665 Shares Traded - Short Shares: 792,534 30.6%

12/3: 4,894,225 Shares Traded - Short Shares: 2,858,364 58.4%

12/4: 6,053,177 Shares Traded - Short Shares - 2,686,009 44.4%

6,336,907 Short Shares Over the last three sessions.

p.s. Anyone who has followed penny stocks are aware that this could run substantially higher than Jason Napadano's valuation of .20 as the shorts panic and cover. Interesting days ahead.

There's been a number of major accomplishments in the last twelve months. Obviously you haven't been following the company very closely.

No, I won't take the time to list them.

Follow the company on Twitter: @AmarantusBio

Tomorrow will be a good test. If it closes above .07 I think we'll see above .10 next week.

Word is getting out.

Almost 45% short volume today.

p.s. The shorts need millions of shares.

.12-.15 range by the end of the month.

Up listing to the NASDAQ by the end of the second quarter of 2014.

How's that for optimism?

p.s. Anyone selling here should get out of the market.

You're going to love being green and up 300% sooner than you think. :)

More green days ahead. Word is getting out.

Closing the year above .10.

"Merry Christmas" and a "Happy New Year" for the shareholders.

Not so much for the shorts.

I told you so!!!

Same thing goes for AMBS.

Just saying.

Amarantus at LD Micro 6th Annual Conference, December 3, 2013

http://ir.stockpr.com/amarantus/videos/view/124/amarantus-at-ld-micro-6th-annual-conference-december-3-2013

They need tens of millions of shares to cover. Grant news or partnership news triples the share price and converts the warrants and moves the company to an up listing on the NASDAQ.

Not if but when.

Gift at a nickle.

You tend to ignore all the major accomplishment that Gerald and the company have achieved over the last twelve months.

The foundation is in place. The seeds are planted.

Anyone who doesn't see this should stick to playing poker and hope that luck is on their side for any given hand.

Buying at the bottom is always a good thing.

Just saying!!!

The poker analogy is substantially meaningless. I would say that poker is 10% skill and 90% luck. The best poker players in the world will admit to having gone broke a number of times.

If you view buying shares of AMBS at the current share price as the same as sitting down at a poker table with a stack equal to ten big blinds I think you are mistaken.

What anyone posts on this board isn't going to affect my decision to continue to hold my AMBS shares.

I've spoken to Gerald eight times since February. Prior to speaking with him the first time I was flipping the stock. Over the last nine moths I have been acquiring shares and will continue to do so.

I think I have a good "read" on Gerald and the "pot odds" favor buying more shares of AMBS especially at the current price.

Everyone is entitled to their opinion.

p.s. I've seen a Royal Flush "flopped" only one time. That was about five years ago at the "Orleans" in Las Vegas. I'm thinking "AMBS" might be the second one.

I think I'd be 100% correct in stating that Gerald didn't comment about MANF as it relates to the field of diabetes.

Just saying!!!

p.s. Buy a few shares before it gaps higher.

Up listing to NASDAQ in second quarter 2014.

As I've stated before 99% of the individuals that will own AMBS shares two years from today still haven't heard about the company.

Buying at the bottom is always a good starting point.

Follow the company on Twitter: @AmarantusBio

Worth checking out if you haven't before:

http://www.amarantus.com/about-us/board-of-advisors

It would be a good time for Gerald to announce that the second orphan indication for MANF is in the field of diabetes and that Novartis is the interested party.

Just saying!!!

If GDNF was worth $200,000,000 a number of years ago why wouldn't MANF be worth $500,000,000 today?

Just a thought!!!

p.s. Something to consider.

It's only a matter of time before the share price triples and the shareholders convert the warrants and the company up lists to the NASDAQ.

Stay on the sideline and miss the opportunity for substantial profits over the next three to five years.

Opportunities like AMBS are very rare indeed.

p.s. Do you think there's a few individuals that regret having sold Amgen shares for less than a dime?

Everyone wants cheaper shares before the share price triples.

Follow the company on Twitter: @AmarantusBio

Is anyone here attending today's presentation?

http://finance.yahoo.com/news/amarantus-bioscience-present-ld-micro-141947739.html

If so please ask Gerald about MANF and the field of diabetes.

Ending the year above .10 would bode well for 2014.

Buy a few shares before the share price gaps higher.

Follow the company on Twitter: @AmarantusBio .... 8,420 followers

p.s. Diabetes + MANF + Novartis = $$$$$

Yuan Passes Euro as 2nd-Most Used Trade-Finance Currency

http://www.bloomberg.com/news/2013-12-03/yuan-passes-euro-to-be-second-most-used-trade-finance-currency.html

The Chinese want the Yuan to replace the dollar as the world standard currency. China will continue to accumulate gold.

p.s. Gold is oversold and so is ABX.

Yuan Passes Euro as 2nd-Most Used Trade-Finance Currency

http://www.bloomberg.com/news/2013-12-03/yuan-passes-euro-to-be-second-most-used-trade-finance-currency.html

The Chinese want the Yuan to replace the dollar as the world standard currency. China will continue to accumulate gold.

p.s. Gold is oversold.